Increased T regulatory cells lead to development of Th2 immune response in male SJL mice

References

• Tang Q, Bluestone JA. The Foxp3+ regulatory T cell: A jack of all trades, master of regulation. Nat Immunol. 2008; 9:239–244.
   PubMed Web of Science ®Google Scholar
• Brusko TM, Putnam AL, Bluestone JA. Human regulatory T cells: Role in autoimmune disease and therapeutic opportunities. Immunol Rev. 2008; 223:371–390.
   PubMed Web of Science ®Google Scholar
• Belkaid Y. Role of Foxp3-positive regulatory T cells during infection. Eur J Immunol. 2008; 38:918–921.
   PubMed Web of Science ®Google Scholar
• Van Wijk F, Roord ST, Vastert B, De Kleer I, Wulffraat N, Prakken BJ. Regulatory T cells in autologous stem cell transplantation for autoimmune disease. Autoimmunity. 2008; 41:585–591.
   PubMed Web of Science ®Google Scholar
• Houot R, Perrot I, Garcia E, Durand I, Lebecque S. Human CD4+CD25high regulatory T cells modulate myeloid but not plasmacytoid dendritic cells activation. J Immunol. 2006; 176:5293–5298.
   PubMed Web of Science ®Google Scholar
• Misra N, Bayry J, Lacroix-Desmazes S, Kazatchkine MD, Kaveri SV. Cutting edge: Human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells. J Immunol. 2004; 172:4676–4680.
   PubMed Web of Science ®Google Scholar
• Cederbom L, Hall H, Ivars F. CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur J Immunol. 2000; 30:1538–1543.
   PubMed Web of Science ®Google Scholar
• McKee S, Pearce EJ. CD25+CD4+ cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development. J Immunol. 2004; 173:1224–1231.
   PubMed Web of Science ®Google Scholar
• Veldhoen M, Moncrieffe H, Hocking RJ, Atkins CJ, Stockinger B. Modulation of dendritic cell function by naive and regulatory CD4+ T cells. J Immunol. 2006; 176:6202–6210.
   PubMed Web of Science ®Google Scholar
• Wu AJ, Hua H, Munson SH, McDevitt HO. Tumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice. Proc Natl Acad Sci USA. 2002; 99:12287–12292.
   PubMed Web of Science ®Google Scholar
• Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, Mauri C. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med. 2004; 200:277–285.
   PubMed Web of Science ®Google Scholar
• Esensten JH, Wofsy D, Bluestone JA. Regulatory T cells as therapeutic targets in rheumatoid arthritis. Nat Rev Rheumatol. 2009; 5:560–565.
   PubMed Web of Science ®Google Scholar
• Sempere-Ortells JM, Perez-Garcia V, Marin-Alberca G, Peris-Pertusa A, Benito JM, Marco FM, Zubcoff JJ, Navarro-Blasco FJ. Quantification and phenotype of regulatory T cells in rheumatoid arthritis according to disease activity score-28. Autoimmunity. 2009; 42:636–645.
   PubMed Web of Science ®Google Scholar
• Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med. 2004; 199:971–979.
   PubMed Web of Science ®Google Scholar
• Venken K, Hellings N, Thewissen M, Somers V, Hensen K, Rummens JL, Medaer R, Hupperts R, Stinissen P. Compromised CD4+CD25high regulatory T-cell function in patients with relapsing–remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level. Immunology. 2008; 123:79–89.
   PubMed Web of Science ®Google Scholar
• Salomon B, Lenschow DJ, Rhee L, Ashourian N, Singh B, Sharpe A, Bluestone JA. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity. 2000; 12:431–440.
   PubMed Web of Science ®Google Scholar
• Zhang X, Koldzic DN, Izikson L, Reddy J, Nazareno RF, Sakaguchi S, Kuchroo VK, Weiner HL. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. Int Immunol. 2004; 16:249–256.
   PubMed Web of Science ®Google Scholar
• Yu P, Gregg RK, Bell JJ, Ellis JS, Divekar R, Lee HH, Jain R, Waldner H, Hardaway JC, Collins M, Kuchroo VK, Zaghouani H. Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen. J Immunol. 2005; 174:6772–6780.
   PubMed Web of Science ®Google Scholar
• Kohm AP, Carpentier PA, Anger HA, Miller SD. Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J Immunol. 2002; 169:4712–4716.
   PubMed Web of Science ®Google Scholar
• Matsushima GK, Stohlman SA. Immunological disorders of SJL mice. In: Rohova B, Vetvicka V. editors. Immunological Disorders of Mice. Boca Raton, FL: CRC Press; 1990. 77–94.
   Google Scholar
• Cua DJ, Hinton DR, Kirkman L, Stohlman SA. Macrophages regulate induction of delayed-type hypersensitivity and experimental allergic encephalomyelitis in SJL mice. Eur J Immunol. 1995; 25:2318–2324.
   PubMed Web of Science ®Google Scholar
• Matsushima GK, Stohlman SA. Maturation of the delayed-type hypersensitivity response in SJL mice: Absence of effector cell induction. Eur J Immunol. 1988; 18:1411–1416.
   PubMed Web of Science ®Google Scholar
• Cua DJ, Hinton DR, Stohlman SA. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2-mediated suppression of autoimmune disease. J Immunol. 1995; 155:4052–4059.
   PubMed Web of Science ®Google Scholar
• Stohlman SA, Matsushima GK, Casteel N, Frelinger JA. The defect in delayed-type hypersensitivity of young adult SJL mice is due to lack of functional antigen-presenting cells. Eur J Immunol. 1985; 15:913–917.
   PubMed Web of Science ®Google Scholar
• Bebo BFJr, Zelinka-Vincent E, Adamus G, Amundson D, Vandenbark AA, Offner H. Gonadal hormones influence the immune response to PLP 139–151 and the clinical course of relapsing experimental autoimmune encephalomyelitis. J Neuroimmunol. 1998; 84:122–130.
   PubMed Web of Science ®Google Scholar
• Cua DJ, Coffman RL, Stohlman SA. Exposure to T helper 2 cytokines in vivo before encounter with antigen selects for T helper subsets via alterations in antigen-presenting cell function. J Immunol. 1996; 157:2830–2836.
   PubMed Web of Science ®Google Scholar
• Cua DJ, Stohlman SA. In vivo effects of T helper cell type 2 cytokines on macrophage antigen-presenting cell induction of T helper subsets. J Immunol. 1997; 159:5834–5840.
   PubMed Web of Science ®Google Scholar
• Tarbell KV, Petit L, Zuo X, Toy P, Luo X, Mquadmi A, Yang H, Suthanthiran M, Mojsov S, Steinman RM. Dendritic cell-expanded, islet-specific CD4+CD25+CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. J Exp Med. 2007; 204:191–201.
   PubMed Web of Science ®Google Scholar
• Mahnke K, Johnson TS, Ring S, Enk AH. Tolerogenic dendritic cells and regulatory T cells: A two-way relationship. J Dermatological Sci. 2007; 46:159–167.
   PubMed Web of Science ®Google Scholar
• Tamura C, Nakazawa M, Kasahara M, Hotta C, Yoshinari M, Sato F, Minami M. Impaired function of dendritic cells in alymphoplasia (aly/aly) mice for expansion of CD4+CD25+ regulatory T cells. Autoimmunity. 2006; 39:445–453.
   PubMed Web of Science ®Google Scholar
• Whitacre CC. Sex differences in autoimmune disease. Nat Immunol. 2001; 2:777–780.
   PubMed Web of Science ®Google Scholar
• Liva SM, Voskuhl RR. Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production. J Immunol. 2001; 167:2060–2067.
   PubMed Web of Science ®Google Scholar
• Wilcoxen SC, Kirkman E, Dowdell KC, Stohlman SA. Gender-dependent IL-12 secretion by APC is regulated by IL-10. J Immunol. 2000; 164:6237–6243.
   PubMed Web of Science ®Google Scholar
• Kim S, Voskuhl RR. Decreased IL-12 production underlies the decreased ability of male lymph node cells to induce experimental autoimmune encephalomyelitis. J Immunol. 1999; 162:5561–5568.
   PubMed Web of Science ®Google Scholar
• Kirwin SJ, Dowdell KC, Hindinger C, Feng N, Bergmann CC, Hinton DR, Stohlman SA. Altered neuroantigen-specific cytokine secretion in a Th2 environment reduces experimental autoimmune encephalomyelitis. J Neuroimmunol. 2006; 178:30–39.
   PubMed Web of Science ®Google Scholar
• Stohlman SA, Pei L, Cua DJ, Li Z, Hinton DR. Activation of regulatory cells suppresses experimental allergic encephalomyelitis via secretion of IL-10. J Immunol. 1999; 163:6338–6344.
   PubMed Web of Science ®Google Scholar
• Malek TR, Yu A, Vincek V, Scibelli P, Kong L. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity. 2002; 17:167–178.
   PubMed Web of Science ®Google Scholar
• Nishioka T, Shimizu J, Iida R, Yamazaki S, Sakaguchi S. CD4+CD25+Foxp3+ T cells and CD4+CD25− Foxp3+ T cells in aged mice. J Immunol. 2006; 176:6586–6593.
   PubMed Web of Science ®Google Scholar
• Romagnoli P, Tellier J, Meerwiijk JPV. Genetic control of thymic development of CD4+CD25+Foxp3+ regulatory T lymphocytes. Eur J Immunol. 2005; 35:3525–3532.
   PubMed Web of Science ®Google Scholar
• Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001; 19:683–765.
   PubMed Web of Science ®Google Scholar
• Chen X, Subleski JJ, Kopf H, Howard OM, Mannel DN, Oppenheim JJ. Cutting edge: Expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells: Applicability to tumor-infiltrating T regulatory cells. J Immunol. 2008; 180:6467–6471.
   PubMed Web of Science ®Google Scholar
• Fu S, Yopp AC, Mao X, Chen D, Zhang N, Mao M, Ding Y, Bromberg JS. CD4+CD25+CD62+ T-regulatory cell subset has optimal suppressive and proliferative potential. Am J Transplant. 2004; 4:65–78.
   PubMed Web of Science ®Google Scholar
• Holmberg D, Cilio CM, Lundholm M, Motta V. CTLA-4 (CD152) and its involvement in autoimmune disease. Autoimmunity. 2005; 38:225–233.
   PubMed Web of Science ®Google Scholar
• Sansom DM, Walker LS. The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology. Immunol Rev. 2006; 212:131–148.
   PubMed Web of Science ®Google Scholar
• Ise W, Kohyama M, Nutsch KM, Lee HM, Suri A, Unanue ER, Murphy TL, Murphy KM. CTLA-4 suppresses the pathogenicity of self antigen-specific T cells by cell-intrinsic and cell-extrinsic mechanisms. Nat Immunol. 2010; 11:129–135.
   PubMed Web of Science ®Google Scholar
• Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol. 2003; 4:337–342.
   PubMed Web of Science ®Google Scholar